Clinical trials
Asthma Patients clinical trials
Below are recruiting asthma patients clinical trials, each written for real people, not researchers. We’re tracking 75 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06637254Enrolling by invitationPhase 2
Testing an oral tablet for hard-to-control asthma
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06137040RecruitingEarly Phase 1
Early IV Magnesium for Moderate Asthma in Children
This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.
Oklahoma City, OklahomaAges 5–17 - NCT06360393Recruiting
Checking inhaler use with a smart spacer for severe asthma on biologics
This trial tests if a smart spacer can help people with severe asthma use their inhaler correctly and stick to their medication schedule. It’s for adults already taking biologic drugs for asthma.
Zwolle, OverijsselAges 18 years+ - NCT07168473RecruitingPhase 3
A study of DW1807 for year-round allergies and asthma
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
SeoulAges 19 years+ - NCT04912596Recruiting
Tested albuterol inhaler compared to a standard inhaler for mild asthma
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
AhmedabadAges 20–65 - NCT06750289RecruitingPhase 3
Testing benralizumab for uncontrolled eosinophilic asthma
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
Chandler, ArizonaAges 12–75 - NCT06427018Recruiting
Proteins in airway smooth muscle of asthma patients
This study looks at two proteins, called Ezrin and Pip5k1α, in the smooth muscle of the airways of people with asthma. By comparing samples from people with and without asthma, researchers hope to understand how these proteins may be involved in asthma.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06460597Recruiting
Breathing techniques for asthma with mood issues
This study compares two gentle breathing methods—Papworth Technique and Pranayama (yogic breathing)—to see which helps people with asthma who also feel stressed, anxious, or down. If you have mild to moderate asthma and often feel negative moods, this trial could help you find a better way to manage both your breathing and your emotions.
Lahore, Punjab ProvinceAges 20–40 - NCT06660537Recruiting
Balloon breathing exercises for asthma patients
This trial tests whether doing balloon-blowing exercises in a specific lying position can improve lung function in people with mild asthma. It may help you breathe easier.
Rawalpindi, Punjab ProvinceAges 18–59 - NCT07508280Recruiting
Energy-saving vs circuit training for asthma patients
This trial compares two exercise programs to see which helps people with asthma more. You may join if your asthma is mild to moderate and you do not have other serious conditions.
Jhang, Punjab ProvinceAges 30–50 - NCT07363642RecruitingPhase 3
Tezepelumab for severe asthma
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
BeijingAges 12–80 - NCT06314477Recruiting
CPAP treatment for severe uncontrolled asthma with sleep apnea
This trial tests if CPAP (a mask that helps you breathe at night) can improve asthma control in people who have both severe uncontrolled asthma and sleep apnea (a condition where breathing stops and starts during sleep). You should not have been hospitalized for asthma in the last month.
Barcelona, SpainAges 18 years+ - NCT06317909Recruiting
New test for airway inflammation after allergen challenge in mild asthma
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Hanover, Lower SaxonyAges 18–65 - NCT07546981RecruitingPhase 3
New Asthma Inhaler for People on Standard Therapy
This study tests a new three-part asthma inhaler (CHF 5993) in people whose asthma isn't well-controlled even though they're already using two standard asthma medicines together. The goal is to see if adding this new medicine helps control asthma better.
Beijing, Chaoyang DistrictAges 18–75 - NCT06966271Recruiting
Lung medication study for asthma or COPD patients
This study uses computer modeling to see how much of your inhaled medication reaches your lungs. It helps doctors understand how to better treat breathing conditions like asthma or COPD.
BudapestAges 18 years+ - NCT06521229Recruiting
Study of uncontrolled mild to moderate asthma in Russia
This study is for adults with mild to moderate asthma that is not well controlled. Researchers will look at medical records to understand what treatments people are using and what their health is like over time.
AstrakhanAges Any age - NCT05724745Recruiting
3D lung breathing test during MRI versus standard spirometry
This study compares a new 3D MRI-based breathing test with the usual breathing test called spirometry. It may help doctors measure lung function more precisely in healthy people and in people with asthma, COPD, or after a double lung transplant.
Orsay, FranceAges 18–90 - NCT06472310Recruiting
Study of severe asthma in Russia (CORSAR)
This study looks at the health records of people in Russia with severe, uncontrolled asthma to understand their symptoms and treatments better. It does not involve any new medicine or treatment.
AstrakhanAges 18 years+ - NCT07134686Recruiting
Combined lung and ear-nose-throat care for asthma and sinusitis
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
MarseilleAges 18 years+ - NCT07189806Recruiting
Asthma study tracking symptoms over 5 years
This study follows adults with mild, moderate, or severe asthma to better understand the condition. You'll attend regular check-ups at the clinic to monitor your lung function and symptoms over five years.
LondonAges 18 years+ - NCT06147453Enrolling by invitation
Oscillating positive expiratory pressure therapy for mucus in asthma
This trial tests a device that uses vibrations to help clear mucus from your lungs. It may improve airflow and mucus buildup in people with moderate to severe asthma.
Hamilton, OntarioAges 18 years+ - NCT06916104Enrolling by invitation
Allergies and biotherapy in severe asthma
This study looks at whether having a respiratory allergy affects how well biotherapy works for people with severe asthma. It includes adults already on biotherapy and followed at Poitiers University Hospital.
PoitiersAges 18 years+ - NCT07025200Recruiting
Severe asthma study using bronchoscopy to check treatment
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
Vienna, State of ViennaAges 18 years+ - NCT07452380Recruiting
Dust mite allergy shot therapy for kids with rhinitis or asthma
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hangzhou, ZhejiangAges 5–18
Hear when a new Asthma Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma patients?
- Yes. Clin2 currently lists 75 recruiting asthma patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.